ArriVent BioPharma Inc — Dividend History & Yield (NASDAQ:AVBP) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Dividends per share — — Dividend yield % — — Payout ratio % — —

新闻

Cantor Fitzgerald重申ArriVent股票评级为"增持"

ArriVent stock rating reiterated as Overweight by Cantor Fitzgerald

Oppenheimer维持ArriVent BioPharma股票"跑赢大盘"评级

Oppenheimer reiterates Outperform rating on ArriVent BioPharma stock

ArriVent BioPharma (AVBP): Its Leading Asset, Furmonertinib, Supports A Cautious Buy

ArriVent BioPharma: A De-Risked Binary With Near-Term Catalysts (NASDAQ:AVBP)

Cantor Fitzgerald 给予ArriVent BioPharma股票"增持"评级

Cantor Fitzgerald initiates ArriVent BioPharma stock with Overweight rating

ArriVent doses first patient in pivotal phase 3 trial for lung cancer drug

BTIG给ArriVent BioPharma股票首次评级为"买入"，看好其肿瘤治疗潜力

ArriVent BioPharma stock initiated with Buy rating at BTIG on oncology potential

Truist证券给予ArriVent BioPharma买入评级，看好其肺癌药物前景